252 related articles for article (PubMed ID: 21731800)
1. Benzothiophene Selective Estrogen Receptor Modulators Provide Neuroprotection by a novel GPR30-dependent Mechanism.
Abdelhamid R; Luo J; Vandevrede L; Kundu I; Michalsen B; Litosh VA; Schiefer IT; Gherezghiher T; Yao P; Qin Z; Thatcher GR
ACS Chem Neurosci; 2011 May; 2(5):256-268. PubMed ID: 21731800
[TBL] [Abstract][Full Text] [Related]
2. An NO donor approach to neuroprotective and procognitive estrogen therapy overcomes loss of NO synthase function and potentially thrombotic risk.
VandeVrede L; Abdelhamid R; Qin Z; Choi J; Piyankarage S; Luo J; Larson J; Bennett BM; Thatcher GR
PLoS One; 2013; 8(8):e70740. PubMed ID: 23976955
[TBL] [Abstract][Full Text] [Related]
3. Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms.
Yu B; Dietz BM; Dunlap T; Kastrati I; Lantvit DD; Overk CR; Yao P; Qin Z; Bolton JL; Thatcher GR
Mol Cancer Ther; 2007 Sep; 6(9):2418-28. PubMed ID: 17876041
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective action of raloxifene against hypoxia-induced damage in mouse hippocampal cells depends on ERα but not ERβ or GPR30 signalling.
Rzemieniec J; Litwa E; Wnuk A; Lason W; Gołas A; Krzeptowski W; Kajta M
J Steroid Biochem Mol Biol; 2015 Feb; 146():26-37. PubMed ID: 24846829
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
[TBL] [Abstract][Full Text] [Related]
6. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC
Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307
[TBL] [Abstract][Full Text] [Related]
7. Benzothiophene selective estrogen receptor modulators with modulated oxidative activity and receptor affinity.
Qin Z; Kastrati I; Chandrasena RE; Liu H; Yao P; Petukhov PA; Bolton JL; Thatcher GR
J Med Chem; 2007 May; 50(11):2682-92. PubMed ID: 17489582
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons.
Zhao L; Brinton RD
Brain Res; 2007 Oct; 1172():48-59. PubMed ID: 17803971
[TBL] [Abstract][Full Text] [Related]
9. Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland.
Peano BJ; Crabtree JS; Komm BS; Winneker RC; Harris HA
Endocrinology; 2009 Apr; 150(4):1897-903. PubMed ID: 19022889
[TBL] [Abstract][Full Text] [Related]
10. Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).
Musa MA; Khan MO; Cooperwood JS
Curr Med Chem; 2007; 14(11):1249-61. PubMed ID: 17504144
[TBL] [Abstract][Full Text] [Related]
11. Uterine peroxidase-catalyzed formation of diquinone methides from the selective estrogen receptor modulators raloxifene and desmethylated arzoxifene.
Liu H; Qin Z; Thatcher GR; Bolton JL
Chem Res Toxicol; 2007 Nov; 20(11):1676-84. PubMed ID: 17630709
[TBL] [Abstract][Full Text] [Related]
12. Chemical modification modulates estrogenic activity, oxidative reactivity, and metabolic stability in 4'F-DMA, a new benzothiophene selective estrogen receptor modulator.
Liu H; Bolton JL; Thatcher GR
Chem Res Toxicol; 2006 Jun; 19(6):779-87. PubMed ID: 16780356
[TBL] [Abstract][Full Text] [Related]
13. The key involvement of estrogen receptor β and G-protein-coupled receptor 30 in the neuroprotective action of daidzein.
Kajta M; Rzemieniec J; Litwa E; Lason W; Lenartowicz M; Krzeptowski W; Wojtowicz AK
Neuroscience; 2013 May; 238():345-60. PubMed ID: 23419549
[TBL] [Abstract][Full Text] [Related]
14. Differential utilization of nuclear and extranuclear receptor signaling pathways in the actions of estrogens, SERMs, and a tissue-selective estrogen complex (TSEC).
Madak-Erdogan Z; Gong P; Katzenellenbogen BS
J Steroid Biochem Mol Biol; 2016 Apr; 158():198-206. PubMed ID: 26689478
[TBL] [Abstract][Full Text] [Related]
15. Structural modulation of oxidative metabolism in design of improved benzothiophene selective estrogen receptor modulators.
Qin Z; Kastrati I; Ashgodom RT; Lantvit DD; Overk CR; Choi Y; van Breemen RB; Bolton JL; Thatcher GR
Drug Metab Dispos; 2009 Jan; 37(1):161-9. PubMed ID: 18936111
[TBL] [Abstract][Full Text] [Related]
16. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
Lewis JS; Jordan VC
Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of selective estrogen receptor modulator (SERM) action.
Dutertre M; Smith CL
J Pharmacol Exp Ther; 2000 Nov; 295(2):431-7. PubMed ID: 11046073
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of oestrogen against oxidative toxicity through activation of G-protein-coupled receptor 30 receptor.
Liu SB; Han J; Zhang N; Tian Z; Li XB; Zhao MG
Clin Exp Pharmacol Physiol; 2011 Sep; 38(9):577-85. PubMed ID: 21645039
[TBL] [Abstract][Full Text] [Related]
19. Differential biochemical and cellular actions of Premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination.
Berrodin TJ; Chang KC; Komm BS; Freedman LP; Nagpal S
Mol Endocrinol; 2009 Jan; 23(1):74-85. PubMed ID: 19036900
[TBL] [Abstract][Full Text] [Related]
20. Selective estrogen receptor modulators: an alternative to hormone replacement therapy.
Bryant HU; Dere WH
Proc Soc Exp Biol Med; 1998 Jan; 217(1):45-52. PubMed ID: 9421206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
